Skip to content
Future from a16z

A new site for understanding the future, how tech shapes it, and how we build it.

Go to Future
It's time to build
Nav Opener
  • Portfolio
  • Team
  • Focus Areas
    • American Dynamism
    • Bio + Health
    • Cultural Leadership Fund
    • Consumer
    • Crypto
    • Enterprise
    • Fintech
    • Growth
    • Talent x Opportunity
  • Content
    Topics
    • Fintech
    • Gaming & Social
    • Security & Privacy
    • Marketplaces
    • Enterprise & SaaS
    • Bio + Health
    • Creator Economy
    • Cryptocurrencies & Blockchains
    Type
    • Articles
    • Video
    • Podcasts
    • Newsletters
  • About
  • Jobs
Close

Justin Larkin

Justin Larkin Twitter LinkedIn

Justin Larkin, MD, is a partner on the Bio investing team, focusing primarily on health technology companies that are transforming the way patients, payors, and providers experience and deliver healthcare.ย 

Prior to joining a16z, Justin led the Strategy and Ops org at Verily (formerly known as Google Life Sciences), working across their portfolio of care delivery, software analytics, and med device business lines. Prior to that, Justin was a co-founder and the product / clinical lead at Wellsheet, a venture-backed health IT company focused on using ML to streamline physician workflows within electronic health records.

Justin holds an MD from the University of Pennsylvania where he was a John Morgan Scholar and a founding member of PennHealthX, an endowed program for cross-disciplinary training in clinical medicine and health technology / entrepreneurship. Justin also holds an MBA from the Stanford Graduate School of Business, as well as a BS / BA from BYU in Developmental Biology and Portuguese, respectively.

Latest Posts

Risk-based Contracting for Value-based Care, a Founder’s Playbook

by Justin Larkin and Julie Yoo
  • bio + health
  • Digital Health Builders
  • go to market
  • healthcare
  • videos

New Year, New Fund, New Opportunities in Bio + Health

by Vineeta Agarwala, Jorge Conde, Justin Larkin, Vijay Pande, Becky Pferdehirt, Jay Rughani, Judy Savitskaya, Daisy Wolf, and Julie Yoo
  • bio + health
  • announcements
  • gene editing including CRISPR
  • healthcare
  • therapeutics
  • when science becomes engineering

Bio Eats World: The Problem with Urgent Care

by Vineeta Agarwala, Justin Larkin, and Lauren Richardson
  • bio + health
  • Digital Health Builders
  • a16z Journal Club
  • digital health
  • healthcare
  • insurance

Doubling down on direct contracting; Can discovery be engineered? Clubhouse FOMO, and more

by Justin Larkin and a16z editorial
  • bio + health
  • care delivery
  • healthcare
  • insurance
  • when science becomes engineering

From @justin_larkinMD

Justin Larkin, MD@justin_larkinMD

We're pumped to be growing our Bio+Health team and are looking for a stellar Healthcare Deal Analyst. DMs open :) https://t.co/mxJiTHFGKm

Justin Larkin, MD@justin_larkinMD

Where does debt fit into the startup capital stack? Check this out! ๐Ÿ‘‡๐Ÿ‘‡๐Ÿ‘‡ https://t.co/Jehwcx07Fb https://t.co/bANWbTZfu6

Julie Yoo@julesyoo

1/ Digital health companies are at the tip of the spear of VBC, as theyโ€™re often implementing novel care models with actions not covered by standard billing codes, and don't have the burden of ossified infra/behavioral norms from decades of FFS as the main way of doing business.

Software is eating the world
© 2022 Andreessen Horowitz
Software is eating the world
    • Twitter
    • Simplecast
  • Contact
  • Jobs
  • Briefings
  • Terms of Use & Privacy
  • Disclosures
  • Conduct
  • Who We Are